Lower Extremity Prosthetics
Customize your policy alerts
Sign up for sierra health and life Policy 2026T0645N alerts
Get alerted when Policy 2026T0645N changes without checking for updates manually.
Monitor payer policy activity
Clinical coverage policy for lower extremity prosthetic devices for UnitedHealthcare Commercial and Individual Exchange members, describing medical necessity, definitions, and applicable billing codes.
Updated Clinical Evidence and References sections to reflect the most current information and archived previous policy version 2026T0645M.
Coverage Criteria and Evidence-based Stances
General coverage stance
Covered when meeting InterQual criteria and member-specific benefits
See InterQual criteria for component- and condition-level requirements; providers should submit required documentation to demonstrate InterQual criteria are met.
Not medically necessary / Unproven devices
The following are explicitly stated as unproven and not medically necessary
Requests are at risk of denial; see clinical evidence for high complication and revision rates.
Applies to the listed amputation levels per policy.
Applies across applicable amputation levels as specified in the policy.
Initial or replacement prosthetic device coverage
Covered when ALL of the following are met
Benefits are provided only for external prosthetic devices; internal/fully implanted devices are covered under medical/surgical benefits.
Device selection and payment limitation
When multiple devices can meet needs
Apply member cost-sharing for upgrades; verify member-specific plan terms.
Coverage-relevant clinical criteria (evidence summary)
Evidence-derived considerations relevant to coverage decisions
Balance documented PRO improvements against substantial complication and revision rates when considering coverage or prior authorization.
Trial fittings and documented functional gains (reduced falls, increased gait speed, improved PROMs) are suggested to justify provision in borderline cases.
Microprocessor Knee (MPK) coverage criteria (evidence-based suggested)
Evidence supports use when ALL/conditional criteria met (per studies and clinical recommendations):
Derived from systematic reviews, randomized and crossover trials recommending individualized trial fittings and outcome documentation prior to authorization.
Powered Ankle (MPA/PwrAF) stance
Evidence is limited and inconsistent; consider as experimental/ investigational unless demonstrated benefit
Hayes reviews and small studies identify inconsistent results, recall bias, small samples, and inability to predict responders; individual trial documentation preferred before coverage.
Powered Hip Prosthesis (prototype) stance
Prototype / early-stage evidence:
Current data derive from mechanical validation and three able-bodied participant functional tests; additional human clinical trials are needed.
Requests for bone-anchored percutaneous limb prostheses (for example, the OPRA Implant System) are considered unproven and not medically necessary due to insufficient evidence of efficacy. This exclusion applies to requests for implantation unless clear, higher-quality evidence establishes safety and durable clinical benefit over conventional socket-suspended prostheses.
Coverage excludes devices provided solely as safety items or to enhance sports-related performance. Repair or replacement requests resulting from misuse, malicious damage, gross neglect, or to replace items that are lost or stolen are not covered under this policy.
Many published OPRA studies explicitly excluded patients with conditions that impair healing, most commonly severe peripheral vascular disease and/or diabetes mellitus. Because these populations were not included in the primary cohorts, evidence on OPRA’s safety and effectiveness does not generalize to patients with these comorbidities.
Current evidence for powered microprocessor prosthetic ankles is limited and inconsistent. The literature does not provide sufficient, high-quality data to support routine coverage for transtibial amputees; available studies are small, often uncontrolled, and show mixed functional results, so routine provision is not supported without documented individual benefit.
The evidence base for powered ankle systems and other advanced prosthetic components is limited by methodological issues including recall bias in survey-based studies, small sample sizes, and unrepresentative samples (for example, all-male responders). These limitations reduce generalizability and impede identification of patient characteristics that predict benefit.
Endoskeletal microprocessor-controlled knee-shin systems that provide variable swing and stance phase control are considered not medically necessary for members functionally classified as K1 or K2. This restriction reflects insufficient evidence of efficacy for low functional-level ambulators.
Use of the OPRA system for transfemoral amputees is not supported by sufficient high-quality evidence. Observational cohorts report mobility gains but also high rates of deep infection, osteomyelitis, mechanical complications, and frequent revisions, raising concerns about the procedure’s safety profile in this population.
Overall evidence for bone-anchored percutaneous limb prostheses in transfemoral amputees is low quality and inconsistent. Given small study sizes, overlapping cohorts, and frequent serious complications, the literature provides unclear support for routine coverage of these procedures for TF amputees.
Routine provision of powered microprocessor ankles is not supported by a consistent body of high-quality evidence. Small comparative studies, surveys, and evolving evidence reviews report variable outcomes and frequent device abandonment; therefore, powered ankles may be considered experimental/ investigational unless objective, documented functional improvements are shown for the individual patient.
In the randomized trial by Kim et al. (2021), there was no significant benefit of a powered prosthesis versus an unpowered prosthesis on metabolic cost, walking speed, physical activity, or perceived mobility. Participants noted concerns about device weight and battery life; the study was limited by small sample size and incomplete real-world data capture.
Applicable Billing Codes and Classification
| L5000 | Partial foot, shoe insert with longitudinal arch, toe filler. |
| L5010 | Partial foot, molded socket, ankle height, with toe filler. |
| L5050 | Ankle, Symes, molded socket, SACH foot. |
| L5060 | Ankle, Symes, metal frame, molded leather socket, articulated ankle/foot (SACH). |
| L5100 | Below knee (BK), molded socket, shin, SACH foot. |
| L5105 | Below knee (BK), plastic socket, joints and thigh lacer, SACH foot. |
| L5150 | Knee disarticulation (or through knee), molded socket, external knee joints, shin, SACH foot. |
| L5160 | Knee disarticulation (or through knee), molded socket, bent knee configuration, external knee joints, shin, SACH foot. |
| L5200 | Above knee (AK), molded socket, single axis constant friction knee, shin, SACH foot. |
| L5210 | Above knee (AK), short prosthesis, no knee joint (stubbies), with foot blocks, no ankle joints, each. |
| L5400 | Immediate postsurgical or early fitting, application of initial rigid dressing, including fitting, alignment, suspension, and one cast change, below knee (BK). |
| L5410 | Immediate postsurgical or early fitting, application of initial rigid dressing, including fitting, alignment and suspension, below knee (BK), each additional cast change and realignment. |
| L5420 | Immediate postsurgical or early fitting, application of initial rigid dressing, including fitting, alignment and suspension and one cast change above knee (AK) or knee disarticulation. |
| L5430 | Immediate postsurgical or early fitting, application of initial rigid dressing, including fitting, alignment and suspension, above knee (AK) or knee disarticulation, each additional cast change and realignment. |
| L5450 | Immediate postsurgical or early fitting, application of nonweight bearing rigid dressing, below knee (BK). |
| L5460 | Immediate postsurgical or early fitting, application of nonweight bearing rigid dressing, above knee (AK). |
| L5500 | Initial, below knee (BK) PTB type socket, nonalignable system, pylon, no cover, SACH foot, plaster socket, direct formed. |
| L5505 | Initial, above knee (AK), knee disarticulation, ischial level socket, nonalignable system, pylon, no cover, SACH foot, plaster socket, direct formed. |
| L5610 | Addition to lower extremity, endoskeletal system, above knee (AK), hydracadence system (and related additions). |
| L5613 | Addition to lower extremity, endoskeletal system, above knee (AK), linkage, with hydraulic swing phase control. |
| L5614 | Addition to lower extremity, endoskeletal system, above knee (AK), linkage, with pneumatic swing phase control. |
| L5615 | Addition, endoskeletal knee-shin system, 4 bar linkage or multiaxial, fluid swing and stance phase control. |
| L5620 | Addition to lower extremity, test socket, below knee (BK). |
| L5637 | Addition to lower extremity, below knee (BK), total contact. |
| L5646 | Addition to lower extremity, below knee (BK), air, fluid, gel or equal, cushion socket. |
| L5686 | Addition to lower extremity, below knee (BK), back check (extension control). |
| L5681 | Addition to lower extremity, below knee (BK)/above knee (AK), custom fabricated socket insert for (initial only). |
| L5682 | Addition to lower extremity, below knee (BK)/above knee (AK), custom fabricated socket insert for (locking mechanism, initial only). |
| L5683 | Addition to lower extremity, below knee (BK)/above knee (AK), custom fabricated socket insert for other than congenital or atypical traumatic amputee, silicone gel, elastomeric or equal, initial only. |
| L5684 | Addition to lower extremity, below knee (BK)/above knee (AK), custom fabricated socket insert for (initial only). |
| L5685 | Addition to lower extremity prosthesis, below knee (BK), suspension/sealing sleeve, with or without valve, any material, each. |
| L5686 | Addition to lower extremity, below knee (BK), back check (extension control). |
| L5688 | Addition to lower extremity, below knee (BK), waist belt, webbing. |
| L5690 | Addition to lower extremity, below knee (BK), waist belt, padded and lined. |
| L5692 | Addition to lower extremity, above knee (AK), pelvic control belt, light. |
| L5694 | Addition to lower extremity, above knee (AK), pelvic control belt, padded and lined. |
| No codes listed |
Prior Authorization, Documentation, and Operational Guidance
Use InterQual criteria and member documentation for coverage decisions
Coverage decisions rely on InterQual CP criteria and the member-specific benefit plan; obtain and submit the clinical documentation required by InterQual and the member's plan when requesting coverage.
- Supply medical records demonstrating the member meets InterQual Durable Medical Equipment, Prosthetics, Lower Extremity criteria.
- Reference and attach the member-specific benefit plan document and any applicable federal or state mandates.
Obtain prior authorization for listed HCPCS/L-codes
Prior authorization is implied for the listed HCPCS/L-codes; obtain plan authorization per the member's benefit requirements before providing the device.
- Include the applicable L-code(s) from the policy's code list with the authorization request.
- Follow the member-specific prior authorization process and submission requirements.
Recommend prior authorization and enhanced justification for bone‑anchored TF prostheses
For osseointegrated (bone‑anchored) transfemoral prostheses, submit a prior authorization with clinical justification, documentation of prior conservative management (socket prosthesis), and informed consent addressing infection and revision risk.
- Explain prior socket-suspended prosthesis intolerance or failure and prior conservative management.
- Document informed consent that discusses high rates of infection, mechanical complications, and revisions reported in the literature.
Document trial fitting and measurable benefit
Consider trial fittings and document objective functional gains (e.g., reduced falls, improved walking speed, balance, or validated PROMs) to support provision of microprocessor knees and other advanced components.
- Provide pre‑ and post‑trial outcome measures (e.g., Q‑TFA, PEQ, ADAPT, gait speed) showing improvement.
- Record acclimation period and trial fitting dates and results.
Check member-specific coverage rules before submitting requests
Verify member-specific coverage rules and the member's benefit plan document before applying this policy; the member document governs coverage decisions and any mandates.
- Confirm whether the device or service is excluded or limited by the member's benefit plan.
- Check applicable federal or state mandates that could alter coverage.
Follow InterQual-based step guidance where applicable
Follow InterQual-based guidance for staged or preparatory device requirements; if InterQual criteria indicate staged fitting or preparatory devices, adhere to those stepwise requirements in documentation and authorization requests.
- Cite the specific InterQual criteria used when submitting clinical documentation.
- Document staged fitting or preparatory device use if required by InterQual.
Limit benefit to device meeting minimum specifications
When multiple devices could meet the member's needs, benefits cover the device meeting minimum specifications; if the member chooses an upgraded device, document that the member will pay the difference.
- Specify the minimum‑spec device and cost baseline in the prior authorization.
- Include a signed acknowledgement if the member elects an upgraded device and accepts additional cost responsibility.
Expect prior socket‑suspended prosthesis use/failure before osseointegration
Document prior use and failure or intolerance of conventional socket‑suspended prostheses before proposing osseointegration; literature and study selection criteria support a ‘socket‑first’ expectation.
- Include records of socket prosthesis problems (pain, skin breakdown, inability to use) and prior treatments tried.
- Summarize why conventional socket management failed or was intolerable for the member.
No single mandatory step therapy sequence specified
There is no explicit, uniform step therapy sequence in this policy; selection of prosthetic components should be individualized based on InterQual and clinical judgment.
- If InterQual specifies steps, follow those criteria; otherwise, individualize device selection and document rationale.
- Do not assume a mandatory universal stepwise sequence applies absent InterQual or benefit plan language.
Provide medical records showing InterQual criteria are met
Medical records may be required to verify InterQual criteria; supply documentation that demonstrates how the member meets InterQual Durable Medical Equipment, Prosthetics, Lower Extremity clinical criteria.
- Include relevant clinical notes, functional assessments, prior device history, and outcomes of any trial fittings.
- Attach InterQual criteria references or outputs used in the assessment.
Document medical necessity and device replacement rationale
Provide evidence that the prosthetic device replaces a limb/body part and meets medical necessity per the member's benefit plan when requesting initial or replacement devices.
- Include the member-specific definition of medical necessity and documentation demonstrating the device replaces a limb or body part.
- For replacements, document reason for replacement and relate to medical necessity rather than misuse or loss.
Include suggested documentation specific to osseointegration proposals
When proposing osseointegration, document prior socket issues, functional status, patient‑reported outcome measures (e.g., Q‑TFA, SF‑36), and discuss infection and mechanical complication risks reported in long‑term follow‑up.
- Attach PROM scores (Q‑TFA, SF‑36) pre‑ and post‑intervention where available.
- Document discussion of study‑reported risks (deep infection, osteomyelitis, high revision rates) in informed consent.
Document functional status and trial outcomes (K‑level, PROMs, performance tests)
Document the member's MFCL/K‑level, acclimation and trial fitting outcomes, and validated patient‑reported and performance‑based measures (e.g., ADAPT, PEQ, gait speed) when seeking coverage for microprocessor knees or advanced components.
- Record the K‑level assessment and how it matches the evidence base (e.g., K2 vs K3/K4).
- Provide baseline and post‑trial performance measures and PROMs to support functional benefit.
Verify member benefit and applicable mandates
Verify member benefit terms and any federal/state mandates before finalizing coverage decisions; failure to reference the member's plan document can lead to denial.
- Confirm exclusions or limitations in the member's specific benefit plan that could bar coverage.
- Document compliance with any applicable mandates in the prior authorization or appeal.
Bone‑anchored prostheses are considered not medically necessary (denial risk)
Requests for bone‑anchored percutaneous limb prostheses (e.g., OPRA) are considered unproven and not medically necessary and are at risk of denial unless strong, plan‑allowed clinical justification is provided.
- If submitted, include high‑quality comparative evidence and justification addressing high revision and infection rates reported in the literature.
- Expect payor review to categorize OPRA/osseointegration requests as unproven for transfemoral amputees.
MPKs for K1/K2 are not medically necessary (denial risk)
Requests for microprocessor‑controlled knee systems for members with MFCL K1 or K2 are considered not medically necessary and may be denied.
- Document the member's K‑level; do not request MPK coverage for K1 or K2 without compelling justification.
- If K2 candidates are considered, provide trial fitting data and InterQual justification per policy guidance.
Coverage exclusions and member cost responsibility
If a device or replacement is specifically excluded by the member's benefit plan, the device is not covered; if the member elects an upgraded device, payment is limited to the cost of the minimum‑spec device and the member is responsible for the difference.
- Check for exclusions (e.g., devices used for sports performance) in the member's plan prior to authorization.
- Obtain member acknowledgement and cost‑sharing information when an upgraded device is chosen.
Excluded replacement reasons may lead to denial
Repair or replacement due to misuse, malicious damage, gross neglect, or to replace lost/stolen items may be excluded—document the cause of damage and relate it to covered replacement criteria.
- If denial is possible, provide documentation showing normal use and medical need rather than misuse or neglect.
- For lost/stolen claims, include police reports or member attestations as required by the plan.
Documented high complication and revision risks for bone‑anchored prostheses
Bone‑anchored transfemoral prostheses have reported high rates of revisions, infections (including osteomyelitis), and mechanical complications; include these risk data in the authorization and informed consent and expect payor scrutiny.
- Cite published implant survival, revision‑free and infection rates when presenting justification.
- Provide plan for infection monitoring, complication management, and rehabilitation when sought.
Risk of denial due to insufficient or low‑quality evidence
Insufficient or low‑quality evidence for some devices and long‑term outcomes may lead to denials when strong comparative evidence or documented functional benefit are not provided.
- Provide high‑quality evidence or objective pre/post trial data to address evidence gaps cited in the policy.
- Expect denials when requests rely solely on small observational studies without clear functional benefit.
Verify member benefit and applicable mandates before approval
Always reference the member‑specific benefit plan document and any applicable federal/state mandates when making coverage decisions; conflicts are governed by the member's plan.
- Document the governing member plan and any applicable mandates with the request.
- If Medicare Advantage applies, note absence or presence of NCD/LCD guidance and cite MAO rationale if used.
Clinical Background and Scope
Background: Lower extremity prostheses are provided across amputation levels to restore mobility. Functional classification using K0–K4 (MFCL) guides component selection, and advanced devices are evaluated relative to these functional levels when assessing potential benefit.
Key Definitions and Terms
Policy Revision History
Updated Clinical Evidence and References sections; archived previous policy version 2026T0645M.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.